You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLONIDINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clonidine Hydrochloride patents expire, and what generic alternatives are available?

Clonidine Hydrochloride is a drug marketed by Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, Xgen Pharms, Zydus Pharms, Actavis Elizabeth, Ajanta Pharma Ltd, Amneal Pharms Ny, Chartwell Rx, Dr Reddys Labs Sa, Endo Operations, Jubilant Generics, Novast Labs, Somerset Theraps Llc, Xiamen Lp Pharm Co, Alembic Pharms Ltd, Am Therap, Aurobindo Pharma Ltd, Chartwell Molecules, Duramed Pharms Barr, Impax Labs, Interpharm, Par Pharm, Prinston Inc, Rising, Sun Pharm Inds Inc, Teva, Unichem, Url Labs, Warner Chilcott, Watson Labs, and Yung Shin Pharm. and is included in fifty-seven NDAs.

The generic ingredient in CLONIDINE HYDROCHLORIDE is chlorthalidone; clonidine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLONIDINE HYDROCHLORIDE?
  • What are the global sales for CLONIDINE HYDROCHLORIDE?
  • What is Average Wholesale Price for CLONIDINE HYDROCHLORIDE?
Drug patent expirations by year for CLONIDINE HYDROCHLORIDE
Recent Clinical Trials for CLONIDINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad Simón BolívarPhase 3
National Cancer Institute, EgyptN/A
Sollis Therapeutics, Inc.Phase 3

See all CLONIDINE HYDROCHLORIDE clinical trials

Pharmacology for CLONIDINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for CLONIDINE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
KAPVAY Extended-release Tablets clonidine hydrochloride 0.1 mg and 0.2 mg 022331 1 2011-03-04

US Patents and Regulatory Information for CLONIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 072138-001 Jun 13, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Molecules CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 071785-001 Apr 5, 1988 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic Pharms Ltd CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 091368-003 Dec 6, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Par Pharm CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE chlorthalidone; clonidine hydrochloride TABLET;ORAL 071142-001 Dec 16, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Interpharm CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 071253-001 Oct 1, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.